NKTR Competitors & Alternatives
Compare Nektar Therapeutics with similar stocks in the same industry
Biotechnology
NKTR
Main Stock$37.22
Tradestie Score
62
Market Cap
$1.12B
Revenue Growth
-0.1%
Analyst Upside
+257.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.73
|
$1.42B | - | 43 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.38
|
$1.35B | - | 59 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.12
|
$1.32B | - | 54 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.29
|
$1.29B | - | 44 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.05
|
$1.29B | - | 53 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.04
|
$1.29B | - | 57 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.23
|
$1.28B | - | 47 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.56
|
$1.27B | - | 58 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
More NKTR Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry